Hello,



  • This field is for validation purposes and should be left unchanged.
EECO2 Privacy Policy

Latest News

HVAC controls optimisation at pharmaceutical manufacturing facility

Posted on

Using HVAC controls optimisation, EECO2 have identified 5,847,000 kWh of annual energy savings, equating to $900,000 USD, over two pharmaceutical manufacturing sites in Puerto Rico. 

EECO2 identified, following initial energy reviews carried out across both manufacturing sites, that the heating, ventilation and air conditioning (HVAC)
and building management system (BMS) were not operating optimally and that efficiency improvements could be realised.

While the HVAC systems were delivering compliant facility temperature and humidity control, the systems were delivering this at an energy expense with failed equipment.
In addition to the energy cost, it was suspected that control devices and readings within the BMS may have been from faulty sensors and valves, often
leading to manual interventions to the systems which can reduce the ability of the system to respond efficiently to environmental conditions, both internally and externally.

Our brief therefore included the identification and implementation of remediation work to correct and clear any underlying faults.

Click here to read the full ‘HVAC controls optimisation’ case study on this project.

To see all other case studies – including more HVAC controls optimisation, click here.

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

First up, it is the #CIBSEShortlist for Building Performance Consultancy (up to 50 employees):
EECO2 @EECO2_Energy
FairHeat @FairHeat
grfn @ConsultGRFN
Lawler Consulting formerly known as Noel Lawler Consulting Engineers @Lawler_Consult
#BPA2021

Proud to announce that EECO2 has been shortlisted for the CIBSE Building Performance Awards 2021 #BPA2021 #welldoneteam @CIBSEAwards #fingerscrossed

Pfizer and BioNTech announce trial data showing COVID-19 vaccine is more than 90% effective. https://twitter.com/i/events/1325768958331383809

#pharma #COVID19

Sign up to the knowledge hub

  • By completing this form, you confirm that we may contact you via email, that you are over the age of 16 and that we can send you periodic emails, containing useful and interesting information including our email newsletter. Please see our privacy policy for more information and to see how you can manage your consent.

  • Fields marked with an * are mandatory